During the past decade, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital" #1 sponsor was "King's College London" with 2 trials, followed by "TauRx Therapeutics Ltd" with 2 trials sponsored, "Actelion" with 1 trials sponsored, "CENTOGENE GmbH Rostock" with 1 trials sponsored and "Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital" #1 collaborator was "University of Oxford" with 2 trials as a collaborator, "Imperial College London" with 1 trials as a collaborator, "Neuroscience Technologies S.L.P" with 1 trials as a collaborator and "Sheffield Teaching Hospitals NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital" are "Chronic Pain" (2 trials), "Multiple Sclerosis" (2 trials), "ALS" (1 trials), "Alzheimer's Disease" (1 trials) and "Behavioral Variant Frontotemporal Dementia" (1 trials). Many other conditions were trialed in "Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital" in a lesser frequency.

Most popular intervention types in "Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital" are "Drug" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Observation" (2 trials), "LMTM" (1 trials), "Ponesimod" (1 trials) and "TRx0237" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".